FDA Approved: PREMARIN — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved a supplemental application for PREMARIN (conjugated estrogens), resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoestrogenism
• Menopause-related Vasomotor Symptoms
• Postmenopausal Osteoporosis
• Vaginal Atrophy

Drugs mentioned

• PREMARIN (Conjugated estrogens)

Snippet

SUPPL AP for PREMARIN (CONJUGATED ESTROGENS)